Hazards of Diagnostic and Therapeutic Use of Radioactive Iodines in Thyroid Disorders
Report of the 24th Annual Meeting of the European Thyroid Association
Per Hall, M. D., Ph. D.
Department of Cancer Epidemiology, Radiumhemmet, Karolinska University Hospital, Stockholm, Sweden
Introduction
Radiation-associated cancer
Cancer risks after diagnostic doses of radioiodine
Cancer risk after
131
I treatment for hyperthyroidism
Cancer risk after
131
I treatment for thyroid cancer
The Chernobyl accident
Conclusion
Author
References